Back
Equinix Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
50
EQIX
Equinix
Last Price:
757.14
Seasonality Move:
4.44%
Buy
77
MIRM
Mirum Pharmaceuticals
Last Price:
34.15
Seasonality Move:
6.63%
Sell
50
Equinix (EQIX)
is a Sell
Is Equinix a Buy, Sell or Hold?
- The current Equinix [EQIX] share price is $756.60. The Score for EQIX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EQIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $34.19. The Score for MIRM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EQIX Stock Price Chart
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $34.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
EQIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.3 | Sell |
| Relative Strength Index (14 RSI): | 48.36 | Sell |
| Chaikin Money Flow: | -319099 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (752.62 - 767.78) | Sell |
| Bollinger Bands (100): | (739.24 - 853.68) | Sell |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 66.2 | Buy |
| Chaikin Money Flow: | 1534746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.34 - 31.66) | Buy |
| Bollinger Bands (100): | (24.32 - 29.22) | Buy |
EQIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 756.02 | Buy |
| 20-day SMA: | 759.08 | Sell |
| 50-day SMA: | 754.83 | Buy |
| 200-day SMA: | 785.85 | Sell |
| 8-day EMA: | 754.39 | Buy |
| 20-day EMA: | 758.44 | Sell |
| 50-day EMA: | 765.85 | Sell |
| 200-day EMA: | 778.13 | Sell |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.57 | Buy |
| 20-day SMA: | 28.83 | Buy |
| 50-day SMA: | 26.5 | Buy |
| 200-day SMA: | 28.22 | Buy |
| 8-day EMA: | 32.4 | Buy |
| 20-day EMA: | 29.9 | Buy |
| 50-day EMA: | 27.73 | Buy |
| 200-day EMA: | 27.19 | Buy |
Equinix Earnings Growth & EQIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.58 per share, an increase next quarter of $0.27 per share, an increase this year of $0.53 per share, and an increase next year of $1.36 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
Equinix Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||